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[571 ABSTRACT 
The present invention discloses a group of calcium 
chelating compounds which have a descreased affinity 
for calcium following illumination. These new com- 
pounds contain a photolabile nitrobenzyl derivative 
coupled to a tetracarboxylate Ca2+ chelating parent 
compound having the octacoordinate chelating groups 
characteristic of EGTA or BAPTA. In a first form, the 
new compounds are comprised of a BAPTA-like chela- 
tor coupled to a single 2-nitrobenzyl derivative, which 
in turn is a photochemical precursor of a 2-nitrosoben- 
zophenone. In a second form, the new compounds are 
comprised of a BAPTA-like chelator coupled to two 
2-nitrobenzyl derivatives, themselves photochemical 
prcursors of the related 2-nitrosobenzophenones. 
The present invention also discloses a novel method for 
preparing I-hydroxy- or 1-alkoxy- 1-(2-nitroaryl)-l-aryI 
methanes. Methanes of this type are critical to the prep- 
aration of, or actually constitute, the photolabile Ca2+ 
chelating compounds disclosed and claimed herein. 
13 Claims, 8 Drawing Figures 
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CHELATORS WHOSE AFFINITY FOR CALCIUM 
IS DECREASED BY ILLUMINATION 
This invention was made with Government support 
under Grant NAGW-515 awarded by NASA. The 
Government has certain rights in this invention. 
FIELD OF THE INVENTION 
The present invention relates to photolabile Ca2+ 
chelators whose affinity for calcium is decreased by 
illumination. The present invention also relates to a 
novel method for preparing 1-hydroxy- or l-alkoxy-l- 
(2-nitroaryl)-l-aryl methanes. Methanes of this type are 
either critical to the preparation of, or actually consti- 
tute, the photolabile Ca2+ chelating compounds dis- 
closed and claimed herein. 
BACKGROUND OF THE INVENTION 
One of the most dynamic areas of modern cell biol- 
ogy is the study of the functions of calcium ions inside 
cells. Calcium is already known to control the contrac- 
tion of all known types of muscle, the secretion of hor- 
mones from gland cells and transmitters from nerve 
synapses, plus a multitude of other functions (see Camp- 
bell, 1983). Calcium is also suspected, but not yet 
proven, to be at the center of some of the biggest re- 
maining mysteries in biology, e.g., how a cell decides 
when to grow and divide, how non-muscle cells control 
their own movements, and how the nervous system 
stores learned patterns and memories. For example, the 
two most recent theories of the molecular mechanism of 
neuronal learning (see Kandel, 1981 and Lynch, et al., 
1984) differ in most aspects but agree in postulating that 
minute localized fluctuations in cytostolic free calcium 
levels inside nerve synapses are the key link between 
long-term biochemical changes and the efficiency of 
information transfer at those synapses. To study these 
important physiological processes, it would be ex- 
tremely useful to produce similar fluctuations in free 
calcium levels by independent experimental means. 
This would show to what extent the natural events 
could be mimicked or elicited in response to properly 
controlled calcium changes. 
The present invention describes novel compounds 
that store Ca2+ in a physiologically inactive form until 
illuminated with ultraviolet light, whereupon the Ca2+ 
tends to be released and is free to activate physiological 
processes. The use of light to control the release offers 
tremendous advantages because the intensity, position, 
spatial extent, and duration of a light beam can be con- 
veniently manipulated with great precision. By con- 
trast, the only general means previously available for 
raising Ca2+ inside cells was to administer certain anti- 
biotics extracted from fungi. These drugs, for example 
A23 187 and ionomycin, act by transporting Ca2+ across 
cell membranes, but cannot be controlled in precise 
locale and duration of action, and have major toxic side 
effects. 
The need for photolabile Ca2+ chelators of the type 
disclosed herein has been acknowledged by scientific 
investigators. For example, in a recent review of physi- 
ological and pharmacological manipulations with light 
flashes, Lester and Nerbonne (see Lester, et al., 1982) 
discuss both the need for such photolabile substances 
and their own unsuccessful attempts to synthesize a 
photosensitive chelator comprised of a photoisomeriza- 
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ble azobenzene group and an known calcium chelator 
such as EDTA and EGTA. 
OBJECTS OF THE INVENTION 
It is an object of the present invention to provide a 
new class of photolabile Ca2+ chelators whose affinity 
for calcium is decreased by illumination. 
It is a further object of the present invention to pro- 
vide a method for preparing 1-hydroxy-or l-alkoxy-l- 
(2-nitroary1)- 1-aryl methanes. 
Other objects of the invention will become apparent 
to those skilled in the art from the following descrip- 
tion, taken in connection with the accompanying draw- 
ings. 
SUMMARY OF THE DRAWINGS 
FIG. 1 is a chemical flow chart illustrating the syn- 
thetic pathway leading to nitr-1, nitr-2 and nitr-3. 
FIG. 2 is a chemical flow chart illustrating the pho- 
tolysis of the Ca2+-complex of nitr-2. 
FIG. 3 is a graph showing absorption spectra for 
nitr-2, before illumination, at various Ca2+ concentra- 
tions. 
FIG. 4 is a graph showing absorption spectra for 
nitr-2, illuminated at 365 nm, in the absence of Ca2+. 
FIG. 5 is a graph showing absorption spectra from 
Ca2+-complexes of nitr-2 illuminated at 365 nm for 
varying lengths of time. 
FIG. 6 is a graph showing absorption spectra from 
the nitrosobenzophenone photolysis product at various 
Ca2+ concentrations. 
FIG. 7 is a time-voltage plot illustrating that a neuron 
injected with nitr-2 slightly hyperpolarizes on illumina- 
tion. 
FIG. 8 is a time-voltage plot iIlustrating that illumina- 
tion of a nitr-2 injected neuron elicits an outward cur- 
rent. 
DEFINITION OF TERMS USED HEREIN 
The new photolabile Ca2+ chelators disclosed herein 
are named with hyphens to distinguish the number 1 
from the letter 1, e.g., nitr-1, nitr-2, nitr-3, etc. 
The chemical formulas for some of the compounds 
discussed herein are identified with Roman numerals 
These Roman numerals are used thoughout the specifi- 
cation (see especially, the Detailed Description of the 
Invention section, infra) as a shorthand means of identi- 
fying these compounds. 
As used herein, nitr 1 means a compound comprised 
of 1 -(2-amino-5-( 1 -methox y- 1 -(2-nitrophenyl)methyl)- 
phenoxy)-2-(2’-amino-5‘-methylphe noxy)ethane- 
N,N,N,N’ tetraacetic acid. Nitr-1 is referred to herein 
as compound VIII. 
As used herein, nitr-2 means a compound comprised 
of 1 -(2-amino-5-( 1 -methoxy- 1 -(2-nitro-4,5-methylenedi- 
oxyphenyl)methyl)phenoxy)-2-(2’-amino-5’-methyl- 
phenoxy)-ethane-N,N,N,N tetraacetic acid. Nitr-2 is 
referred to herein as compound XI. 
As used herein, nitr-3 means a compound comprised 
of 1-(2-amino-5-(1-methoxy-1-(2,6-dinitro-3-methoxy- 
phenyl)methyl)phenoxy)-2-(2’-amino-5’-methyl- 
phenoxy)-ethane-N,N,N’,N tetraacetic acid. Nitr-3 is 
referred to herein as compound XIV. 
As used herein, TMS triflate or TMS-OTf means 
trimethylsilyl trifluoromethanesulfonate. 
As used herein, MOPS means 3-(N-morpholino)pro- 
panesulfonic acid. 
4.689,432 - I  ~ 
3 
As used herein, EGTA means ethylene glycol bis(- 
beta-aminoethyl ether)-N,N,N’,N‘-tetracetic acid. 
As used herein, BAPTA means 1,2-bis(2-amino- 
phenoxy)ethane N,N,N’,N‘-tetraacetic acid; the chemi- 
cal structure for BAPTA is: 
As used herein, quid means 2-[[2-[bis(carboxyme- 
thyl)amino]-5-methylphenoxy]-methyl]-8-[bis(carbox- 
ymethyl)amino]-quinoline. 
As used herein, quin2 means 2-[[2-[bis(carboxyme- 
thyl)amino]-5-methylphenoxy]-methyl]-6-methoxy-8- 
[bis(carboxymethyl)amino]-quinoline; the chemical 
structure for quin2 is: 
As used herein, BAPTA-like means substituted deriv- 
atives of BAPTA which retain the essential characteris- 
tic of two bis(carboxymethy1)amino-substituted phenyl 
rings, said rings being linked at the positions ortho to 
the amines through a four atom bridge wherein the 
atom adjacent to each phenyl ring is N or 0 and the two 
center atoms are each C. By this definition, it is meant 
that “BAPTA-like” includes compounds like quin-1 
and quin-2. 
As used herein, pharmaceutically acceptable esters 
mean those readily hydrolyzable esters which are 
known and used in the pharmaceutical industry, espe- 
cially alpha-acyloxyalkyl esters. See generally, Ferres 
(1980) and Wermuth (1980). 
As used herein, pharmaceutically acceptable non- 
toxic salts mean carboxylic acid salts wherein the coun- 
terion or ions are all Na, K, N&+ (where R=H, 
C1-C4 alkyl or a mixture thereof), Ca, or Mg, or some 
combination of these counterions, or some combination 
of acid salts or these counterions plus free acid groups. 
As used herein, [Ca2+]i means intracellular free cal- 
cium. 
As used herein, microM means micromolar. 
Temperatures herein are given in degrees Centigrade. 
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DESCRIPTION OF THE INVENTION 
Brief Description of the Invention 
The present invention comprises a new class of com- 
pounds which, when illuminated, decrease their affinity 
for calcium. The compounds contain a photolabile ni- 
trobenzyl derivative coupled to a tetracarboxylate par- 
25 ent compound having the octacoordinate chelating 
groups characteristic of EGTA or BAPTA. 
In a first form, the new compounds are comprised of 
a BAPTA-like chelator coupled to a single 2-nitroben- 
zyl derivative, which in turn is a photochemical precur- 
3o sor of a 2-nitrosobenzophenone. In this form, the new 
compounds are comprised of a chemical compound 
having the generic formula: 
2o 
I 
45 R5 
and the pharmaceutically acceptable non-toxic salts and 
esters thereof wherein: 
A is -NO2 or -H; 
R1 is selected from the group comprised of -H (un- 
less R2 is also H), -CH3, -F, -C1, and -Br; 
R2 is selected from the group comprised of -H (un- 
less R1 is also H), -CH3, -F, -C1, -Br, and C p c 4  
alkoxy; 
R3, R4and R5are independently -H, OH, NR6R7, or 
alkoxy, or 
R3 and R4 together are -0CHzO- or -0CH2C- 
H20- and R5 is -H, OH, NR6R7, or alkoxy, or 
R4 and R5 together are -0CH20- or OCH2C- 
X is selected from the group comprised of -OH, 
alkoxy, -C1, -Br, -NR6R7, -0COCH3, -0- 
COCF3, -0COCH2NH2, -OP03H, and -0- 
S02CH3; 
R6 and R7 are independently -H, methyl or ethyl; 
D is 0, N, NH, or N alkyl; 
Q is a double bond when D is N and a single bond 
50 
55 
60 H20- and R3 is -H, OH, NR6R7, or alkoxy; 
65 
otherwise; 
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Rsis H and R9is H or 
R8 and R9, together with heteroatom D, the carbon 
adjacent R8, and the phenyl ring adjacent to R9, form a 
quinoline ring system (D=N, Q=double bond); and 
tertiary amine, and about two to four equivalents of 
TMS triflate; then adding thereto about one to two 
equivalents of a 1-formyl-2-nitroaryl compound or a 
dialkoxy acetal thereof; and stirring the reactants until 
Detailed Description of the Invention 
The present invention comprises a new class of tal- 
cium chelating compounds which decrease their affinity 
10 for calcium when exposed to light. Generic formulas for 
these photolabile compounds are given above. 
Compounds of the type disclosed and claimed herein 
consist of a Ca2+ chelating portion and a nitro aryl 
portion, connected by a substituted methylene bridge. 
l5 Examples of these new photolabile compounds include 
nitr-1, nitr-2, and nitr-3. FIG. 1 outlines the synthetic 
route utilized in preparing these compounds. Full de- 
scriptions of the reaction conditions are described be- 
low. In both the figures and the discussion that follows, 
2o Roman numerals are sometimes used as a shorthand 
means of identifying the various chemical compounds. 
The present invention relies on the use of a novel 
method of condensing 2-nitro benzaldehydes or acetals 
thereof with aryl compounds using trimethylsilyl triflu- 
25 oromethanesulfonate as a condensing agent. Without 
A full description of the method is included herein by 
way of illustration in the synthesis of compounds VII, 
The synthesis of the compounds claimed herein is 
described in the detailed synthesis of nitr-1 (compound 
VIII), nitr-2 (compound XI), and nitr-3 (compound 
XIV), infra. Those skilled in the art will recognize that 
35 other new forms of these photolabile Ca2+ chelators 
can be prepared by using related synthetic methods and 
starting materials. 
Preparations of calcium chelating compounds suit- 
able for use as intermediates in this invention have been 
pounds described therein, those skilled in the art will 
realize that by using standard techniques it is possible to 
prepare derivatives Of said compounds Containing Vari- 
OW R', R2, R8, R9, w and D groups (see generic formu- 
45 las in Brief Description of the Invention Section, Supra). 
W is -H, -OH, or NHR6. Such derivatives are within the scope of the present 
The present invention also comprises a novel method invention. By way of example, the synthesis of 5'-meth- 
for preparing 1 hydroxy- or I-alkoxy-1-(2-nitroaryl)-l- yl-BAPTA, tetramethyl ester (Rl=Rs=R9=W=H, 
aryl methanes. Methanes of this type are either critical R2=CH3, D=O) is illustrated below (compound VIa). 
to the preparation of, or actually constitute, the 50 This synthesis begins with two substituted 2-nitro- 
photolabile Ca2+ chelating compounds disclosed and phenoxides. One skilled in the art will recognize that 
claimed herein. other 2-nitrophenoxides with appropriate R1, R2 and W 
According to the disclosed novel method, 1-hydroxy- substituents can be used in the same way to prepare 
or 1-alkoxy- 1-(2-nitroaryl)-l-aryl methanes having the other BAPTA derivatives. Briefly, the nitrophenoxides 
formula: 55 are condensed sequentially with dibromoethane, re- 
duced (H2/Pd), and alkylated with ethyl or methyl 
bromoacetate. 
Other chelating groups within the scope of the inven- 
tion include derivatives of quinoline (R8 and R9 part of 
60 a quinoline ring). Preparation of quinoline analogs of 
BAPTA has been described (See Tsien, 1980). Similar 
chelating compounds within the scope of this invention 
R=  C1-C4alkyl can be prepared using the methods of Tsien (1980) or 
R10= aryl the teachings of this invention. 
R11= 2-nitroaryl 65 The nitrophenyl portion of the new compounds 
comes from a suitable 2-nitro-benzaldehyde or 2,6-dini- 
trobenzaldehyde. The aldehyde can be used directly to 
prepare compounds containing X=OH, or the alde- 
W is -H, -OH, or -NHR6. 
In a second form, the new compounds are comprised 
of a BAPTA-like chelator coupled to two 2-nitrobenzyl 
derivatives, themselves photochemical precursors of 
the related 2-nitrosobenzophenones. In this form, the 
new are comprised Of a 
pound having the generic formula: 
5 the reaction is complete. 
N(CHzC02Hh 
A 
R4 
and the phamaceuticaily and the condensing agent, the condensation does not work. 
esters thereof wherein: 
A is -NO2 or -H; 
R3, R4and R5are independently -H, OH, NR6R7, or 3o x, and xIII, infra. 
R3 and R4 together are -0CH20- or -0CH2C- 
R4 and R5 together are -0CH20- or -0CH2C- 
alkoxy, or 
H20- and R5 is -H, OH, NR6R7, or alkoxy, or 
H20- and R3 is -H, OH, NR6R7, or alkoxy; 
is selected from the group comprised of 
alkoxy, ~-1, -B~,  -NR6R7, -OCOCH~, -OCOCF~, 
-0COCH2NH2, -OPO3H, and -0S02CH3; 
R6 and R7 are independently -H, methyl or ethyl; 
D is 0, N, NH, or N alkyl; 
Q is a double bond when D is N and a single bond 40 described (See Tsien, 1980). In addition to the COm- 
otherwise; 
RSis H and R9is H or 
R8 and R9, together with heteroatom D, the carbon 
adjacent R8, and the phenyl ring adjacent to R9, form a 
quinoline ring system @=N, QAouble bond); and 
R'O OR 
\c' 
R"' \H . 
wherein: 
are prepared by mixing: about one equivalent of an aryl 
compound which will undergo electrophilic aromatic 
substitution, about one to two equivalents of a hindered 
7 
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hyde can be modified to an acetal, leading to com- 
pounds containing X=Oalkoxy. The advantage of 
using a nitrobenzaldehyde acetal is that the condensa- 
tion of such acetals with BAPTA-like aromatic systems 
proceeds under very mild conditions, using the novel 5 
method described below. Acetals are prepared by react- 
ing substituted nitro-benzaldehydes and methoxytrime- 
thylsilane, using TMS-triflate as a catalyst (see Noyori, 
et al., 1981). 
related compounds to be prepared. When W is -OH, 
-alkoxy, or -NHR6, the heteroatom may exert elec- 
tronic and steric effects to modify the stability of the 
photoactive transition state. R1 and R2 can be altered to 
modify the & of the chelator portion of the molecule, l5 
and to control the electrophilic aromatic substitution of 
The various R and W substituents allow a number of 10 
the nitrobenzaldehyde derivative so that one or two 
photolabile groups are incorporated in the final mole- 
cule. R3 through R5 substituents will influence the elec- 
tron density of the nitrophenyl ring and therefore can 
influence the wavelength needed to activate the photo 
reaction. 
The key step in preparing compounds of the type 
disclosed and claimed herein is the condensation of a 
2-nitrobenzaldehyde9 dialkyl acetal, with an aromatic, 
BAPTA-like chelator. The obvious, textbook methods 
for synthesizing benzhydrols either failed or were un- 
suitable because of the many other substituents on the 
desired molecule. For example, the classic methods for 
condensing aromatic rings with aldehydes or ketones 
(“hydroxyalkylation”, see March, 1977) are known not 
to stop at the benzhydrol stage but to go on to triaryl- 
methanes. Also conventional Lewis acids needed to 
activate the aldehyde would deactivate the BAPTA- 
like substrates because of their amino functionality. 
After many failures with the known methods, surpris- 
ingly we found that by using the new and unusually 
selective Lewis acid, trimethylsilyl trifluoromethane 
sulfonate (see Noyori, et al., 1981), we could carry out 
the required electrophilic aromatic substitution. No 
example has heretofore been recorded of the use of 
TMS-triflate to promote the reaction of aldehydes or 
acetals to form C-C bonds with aromatic substrates. In 
previous work (see Noyori, et al., 1981), the substrates 
were always aliphatic enol silyl ethers, not aromatic 
compounds. Our new method can be practiced by mix- 
ing together one equivalent of an aryl compound and a 
hindered, tertiary amine, then adding TMS-triflate, and 
finally adding a 2-nitroaryl aldehyde or dialkyl acetal 
thereof. By way of example, we have used this method 
to prepare compounds VII, X and XI11 (see synthesis, 
infra). Thus, compound VI1 was prepared by mixing 
5’-methyl-BAPTA-tetramethyl ester with 2,6-di-tert- 
butylpyridine and TMS-triflate, then adding 2-nitroben- 
zaldehyde, dimethylacetal, compound VII, 5-( 1-(2- 
nitropheny1)-1-methoxymethyl) BAPTA, methyl ester. 
In the preparation of compounds of the invention that 
contain only one photolabile nitrobenzyl group, if R2 is 
anything except hydrogen, the 5 position of that ring 
will be blocked and nitrobenzylation can proceed only 
at the desired 5 position of the 4-W-phenyl ring or 
equivalent quinoline or benzopyran. If R2 is hydrogen, 
the presence of halogen at Rl will deactivate that ring 
for electrophilic substitution and nitrobenzylation will 
occur mainly at the desired position. Products of the 
first type where R k H  and R’=H or alkyl can be 
prepared only by controlled nitrobenzylation and sepa- 
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ration of the desired product, so preparation of such 
compounds is not recommended. 
To prepare compounds containing two nitrobenzyl 
groups, R2 must be hydrogen and R1 can be hydrogen, 
alkyl or any form appropriate for substituent W. In this 
case, the desired nitrobenzylation occurs at the 5 posi- 
tion of both phenyl rings or the 5 position of both the 
Rl, R2 phenyl and of the quinoline. 
It is known that cation affinities of BAPTA deriva- 
tives can be increased or decreased by appropriate elec- 
tron-donating or electron-withdrawing substituents (see 
generally Tsien, 1980). For example, substitution of two 
methyl groups for the two hydrogens para to the two 
nitrogens of BAPTA strengthened Ca*+ binding by 0.4 
log unit and similar disubstitution with bromine weak- 
ened Ca2+ binding by 1.2 log units (see generally, Tsien, 
1980). We have found that monosubstitution gives half 
as much effect on calcium affinity (data not shown). 
Those skilled in the art will realize that the effect of 
other substituents on the cation affinities of the present 
compounds should be quantitatively predictable by a 
Hammett-type linear free-energy relation. 
It is also known that the greatest change in chelating 
characteristics occurs within 2 log [Ca2+] units of the 
Kd of any particular chelator (see Tsien, 1980). As a 
result, it would be helpful to have chelators available 
which have a range of Kd’s. To this end, Rl and R2 can 
be varied to adjust the Kdup or down. As expected, the 
nitrobenzyl component of the molecule weakens Ca2+ 
binding by 0-0.3 log units (compare Kd= 160 nM with 
BAPTA Kd= 100 nM, (see Tsien, 1980). 
Chelators containing W=OH and R*=R9=H are 
synthesized in seven steps from p-hydroquinone. By 
way of example, preparation of the BAPTA derivative 
1 -(2-amino-4-hydroxy-phenoxy)-2-(2‘-amino-5’-methyl- 
phenoxy)ethane, N,N,N,N-tetra-acetic acid, tetraethyl 
ester (XXII) is illustrated below in the synthesis of XXII 
from hydroquinone, XV. Key steps in the preparation 
include the acid-catalyzed, selective debenzylation (see 
Marsh, et. al., 1965) of the phenolic group ortho to the 
nitro in preference to the phenolic group meta to nitro. 
The resulting 2-nitro-4 benzyloxyphenol can then be 
condensed with 2-nitro-4-R1-5-R2-phenoxide and 1,2- 
dibromoethane, reduced (H2/Pt), and alkylated with 
ethyl or methyl bromoacetate. Attempts to convert 
XXI to XXI by hydroxide displacement of benzyloxide 
were unsuccessful. The remaining benzyl protecting 
group survives hydrogenation with platinum catalysis 
(see Freifelder, 1971), but is finally removed by hydro- 
genation with palladium. Since the 4-benzyloxy substit- 
uent will accelerate the rate of nitrobenzylation at the 
neighboring 5 position, any combination of R1 and R2 
can be used in preparing compounds containing one 
nitrobenzyl group. 
The preparation of chelators where W=NHR6 
( R k H ,  Me, or Et) and Rs=Rg=H could begin with 
benzyloxycarbonyl protection of 4-(R6-amino)phenol. 
Nitration, nitrosation, or coupling with a suitable diazo- 
nium salt would yield a substituted phenol analogous to 
compound XXI, infra. Such a phenol could be con- 
densed with l-brom0-2-(2-nitro-4-R1-5-R2-phenoxy)e- 
thane, and reduced (H2/Pt). Any of nitro, nitroso or azo 
groups will thereby be reduced to NH2 without affect- 
ing the benzyloxycarbonyl groups. After alkylation 
with alkyl bromoacetate, the benzyloxycarbonyl group 
would be removed by hydrogenation with palladium on 
carbon to give an chelator with W=NHR6. 
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The preparation of chelators in which R8 and R9 are illustrated in FIGS. 7 and 8. Each will be discussed 
part of a quinoline ring, has been described (see Tsien, separately below. As background FIG. 2 is useful since 
1980). Starting with, for example, 2-methyl-6-W-8- it outlines the photolysis mechanism at the molecular 
nitroquinoline, the 2-methyl group is iodinated to iodo- level. 
methyl, then condensed with potassium 2-nitro-4-R1-5- 5 FIG. 3 shows that before photolysis, nitr-2 has a high 
R2-nitrophenoxide. The product is then reduced affinity for Ca2+. In determining this 25 microM nitr-2 
(Pt/H2), and alkylated with methyl or ethyl bromoace- was dissolved in 100 mM KCI, 4 mM dipotassium salt of 
tate (see Tsien, 1980) to give the desired chelator. One N-(hydroxyethyl)-ethylenediamine-N,N’,N’-triacetic 
skilled in the art can use these teachings to prepare acid (HEEDTA), 10 mM tris (hydroxymethyl- 
other compounds containing various groups R1, R2, R8, 10 )aminomethane, 2 mM MOPS, pH 8.84. The absorbance 
and R9. spectrum was then recorded giving the curve labeled 
The preparation Of chelators where R8 and Rg are “()”. Then 2 mM CaC12 was added as well as enough 
part of a quinoline ring and W-H begins, for exam- concentrated KOH to raise the pH to 9.14. At this pH 
ple, with 2-methyl-6-methoxy-8-nitroquino~ine. The the calculated free [Ca2+] in the buffer was 41 nM. The 
methoxY group could be cleaved with BBr3 Or hot HI to 15 spectrum was recorded again. Successive additions of 
yield a 6-hydroxy group, which could then be Protected HCI lowered pH to 8.81 (free Ca2+ 81 nM), 8.57 (free 
by reaction with dimethoxymethane under acid cataly- ca2+ 135 n ~ ) ,  8.33 (free ca2+ 234 n ~ ) ,  8-10 (free 
nitroquinoline. This can be used as starting material for ca2+ 1.585  micro^), and 7-03 (free ca2+ 4-79 micro^). 
sis to yield 2-methyl-6-methoxymethY10xy-8- Ca2+ 398 nM), 7-88 (free Ca2+ 661 nM), 7.50 (free 
the synthesis outlined above for 2-methy1-6-W-8- 2o Though absorption spectra were recorded at each pH, 
nitroquinoline, leading to for clarity only every other curve has been reproduced 
20CH3. acid Of this gives in this figure, each being labeled by the free Ca2+ in 
to raise free Ca2+ to 1 mM, produced no further spec- 
25 tral change, confirming that 4.79 microM free Ca2+ was 
with W-CH- 
units of nM. Addition of 3 mM extra CaC12 at the end, chelators with W S H .  where R8 and R9 are part Of a quinoline 
ring and W=NHR6 be prepared7 for 
already saturating. Analysis of all the absorption at 266 
nm by the usual Hill plot showed that the dissociation 
constant was 160 nM. The method used here for manip- 
ulating free Ca2+ relies on the known facts that 
BAPTA derivatives are practically insensitive to pH as 
HEEDTA is dependent On pH in a known 
from 2-methyl-6-(R6-amino)-8-nitroquinoline by pro- 
tecting the amine as benzyloxycarbonyl, then iodinat- 
ing, condensing with 2-nitro-CRl-5-R2-nitrophenoxide, 
reducing, and alkylating with alkylbromoacetate (see 
Tsien, 1980). Hydrogenation of such a compound with 30 
palladium on carbon gives chelators with W=NHR6. 
herein could also be esterified using an alpha-alkyloxy- 
readily cross cell membranes, but once within the cell 35 
The photolabfie compounds disclosed and claimed above pH 6.5, whereas the Ca2+ affinity Of 
alkyl bromide. Such esters are hydrophobic enough to 
are cleaved by cytosolic esterases to regenerate the free 
acids. By way of example, acetoxymethyl esters of the 
way. were performed under Orange 
FIG. 4 characterizes the photoisomerization of nk -2  
in the &sence ofCa2+. It shows representative absorp- 
to avoid photolysis* 
photolabile compounds discussed and claimed herein 
can me made by : saponifying the methyl or ethyl esters 
of the target chelator (for example, compounds IX, XII, 40 
XVI, ~ ~ ~ 1 1 1 ,  XXXI, or ~ X I V ,  below and in FIG. 1) 
with KOH. adding four to six eouivdents of a tet- 
tion spectra for a sample of 4 microM nitr-2 dissolved in 
Cdcium-free aqueoUS solution containing 130 mM KCL 
brought to pH 7.2 with 
KOH. The curve labeled “0” was measured before any 
exposure of the sample to significant levels of ultravio- 
mM EGTAy lo mM 
rabutylammonium ialt (preferably the hydroxide), and 
evaporating in vacuo to dryness. The residue was then 
extracted with dichloromethane, which dissolved the 
dyes as the tetrabutylammonium salts. This organic 
solution was dried thoroughly in vacuo, and the residue 
was taken up in dichloromethane, mixed with about 
5-10 equivalents (per dye) of acetoxymethyl bromide 
(prepared according to the new method disclosed 
herein, see Acetoxymethyl Bromide, described infra in 
Compound Synthesis) and about 2 equivalents (per dye) 
of ethyl diisopropylamine, then stirred overnight. The 
solvent was then evaporated, the residue was taken up 
in benzene or toluene, washed with aqueous bicarbon- 
ate and water, dried and evaporated. The products were 
generally pure enough for use, but could be further 
purified on silica gel, if necessary. 
Methods for synthesizing the new photolabile Ca*+ 
chelators disclosed herein are outlined in the Com- 
pound Synthesis section infra. Specific properties and 
embodiments of the new chelators, as exemplified by 
the compounds nitr-1, nitr-2, and nitr-3, are discussed in 
Examples I and 11, and the Figures referred to therein. 
Example I discloses and discusses in vitro chemical tests 
using nitr-1 and nitr-2. Results of those tests are illus- 
trated in FIGS. 3-6. Example I1 discloses and discusses 
biological testing of nitr-2. Results of those tests are 
le i  radiation. (Con&ol experiments showed that the 
Cary 210 spectrophotometer used negligible intensity of 
45 UV to measure these spectra). The curves labeled “2”, 
“5”, “13” and “42 min” show the successive spectra 
remeasured after those durations of cumulative expo- 
sure to 365 nm irradiation from an Ultraviolet Products 
Inc. UVGL-58 lamp at a distance of 1 cm. The intensity 
50 at this position had been separately measured to be 
7.8x 10-9 einsteins a cm-2 . sec-1. Spectra were also 
measured at times of 1, 3, 8, 20, and 30 minutes but are 
omitted here merely for graphical clarity; they do con- 
firm that the “42 min” curve represents > 99% comple- 
55 tion of the photochemical change. Solutions were at 
room temperature and continually stirred by a magnetic 
follower during illumination. At these low light levels, 
the conversion of nitr-2 in to its isomeric nitrosoben- 
zophenone is entirely rate-limited by the ability of nitr-2 
such as collapse of the hemiketal. Because the total 
optical density remained low throughout, the optical 
density was expected (see Brown, 1971) and found to 
approach its asymptotic value in an exponential manner. 
65 The quantum efficiency is known (see Brown, 1971) to 
be given by the reciprocal of the product of the time in 
seconds to reach 90% conversion, the incident light 
intensity in einsteins cm-2 . sec-1 and the extinction 
60 to catch photons, not by the subsequent dark reactons, 
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coefficient in cm2- mole-1. In this experiment the quan- 
tum efficiency was found to be 0.03. 
FIG. 5 characterizes the photoisomerization of the 
Ca2+-complex of nitr-2. It shows absorption spectra for 
10 microM nitr-2 dissolved in 130 mM KCl, 1 mM 
CaC12, 10 mM MOPS, pH titrated to 7.2 with KOH. 
Spectra were obtained after 0, 20 sec, 1 min, 2, 3, 5, 8, 
13, and 20 min of 365 nm illumination, exactly as in 
FIG. 4. Again for clarity, only the 0, 1, 3, and 20 minute 
spectra have been reproduced here. The 13 minute and 
20 minute spectra were identical, confirming comple- 
tion of photolysis after those times. It is obvious that 
photoisomerization approaches completion more rap- 
idly here in high [Ca2+] than in zero [Ca2+] (FIG. 4). 
The quantum efficiency was determined to be 0.1 for 
the conversion of Ca2+-nitr-2 to the Ca2+-nitrosoben- 
zophenone studied here. 
FIG. 6 shows that the nitrosobenzophenone photoly- 
sis product has a low affinity for Caz+. The nitrosoben- 
zophenone was produced by dissolving 25 microM 
nitr-2 in 100 mM KCl, 2 mM CaC12, 10 mM tris(hydrox- 
ymethyl)aminomethane, 2 mM MOPS, pH 8.8, and 
irradiating for -20 min with the WGL-58 lamp at 365 
nm to complete the photolysis. The spectrum labeled 
2000 microM was then recorded. 4 mM dipotassium salt 
of HEEDTA was then added, plus enough KOH to 
raise the pH to 10.3 (free Ca2+ < M), whereupon 
the spectrum labeled “‘0” was recorded. Then HCl was 
added in analogy to FIG. 3, to reach the following pH 
and free Ca2+ values in parentheses: 8.53 (0.117 mi- 
croM), 8.13 (0.372 microM), 7.82 (0.759 microM), 7.41 
(1.95 microM), 7.05 (4.57 microM), 6.77 (9.33 microM), 
6.35 (26.3 microM), 5.93 (75.8 microM). The only inter- 
mediate spectra shown in this figure correspond to the 
underlined values. The usual Hill plot showed a dissoci- 
ation constant in the range 7-10 microM. 
FIG. 7 shows that illumination of nitr-2 can raise the 
free [CaZ+] level inside a live nerve cell. A particular 
neuron, conventionally designated L2, in the abdominal 
ganglion of the sea hare Aplysia californica, received a 
microinjection of nitr-2 solution amounting to approxi- 
mately 2% of the cell’s volume. This nitr-2 solution 
contained 400 mM nitr-2 tetraanion, 300 mM Ca2+ with 
the ionic balance made up with K+. The cell therefore 
received about 8 mM nitr-2 and 6 mM Ca2+. It was also 
impaled with a separate microelectrode to record its 
membrane potential. At the time marked by the first 
arrow, a shutter was opened permitting a 75 watt xenon 
arc lamp to illuminate the cell through a quartz focusing 
lens. The membrane potential went more negative (hy- 
perpolarized) as expected for a rise in [Ca2+]i which 
would open a Ca2+-activated potassium conductance in 
the membrane. The effect partly reversed when the 
light was blocked (see second arrow). Development of 
this potassium conductance is one of the best-under- 
stood consequences of elevating [Ca2+liin this cell type. 
There are at least four reasons why the hyperpolariz- 
ing effect was small: (1) Nitr-2 is still far from ideal in 
extinction coefficient and quantum efficiency. (2) The 
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ylsilyl iodide. Although all ester groups in the com- 
1L 
Ca2+ ions there are to be released by light, and the less 
the quantum efficiency of isomerization of nitr-2 to the 
nitrosobenzophenone. Nitr-2 would be expected to be 
much more effective in any vertebrate cell, since verte- 
brates have much lower ionic strengths (- 150 mM). 
FIG. 8 shows an experiment identical to FIG. 7 ex- 
cept that the cell’s electrophysiological response was 
measured differently. Here the cell was maintained 
under voltage clamp, a setup by which an electronic 
feedback amplifier injects into the cell whatever current 
is necessary to maintain the membrane potential at a 
constant value, chosen here to be -35 mV. Before the 
nitr-2 was introduced, illumination had no effect on the 
current required (see trace marked uninjected control). 
After the nitr-2 was injected as in FIG. 7, illumination 
causes the cell membrane to conduct more current out- 
wards. An equal current is injected by the feedback 
amplifier in order to hold the membrane potential con- 
stant. An increased outward current is another manifes- 
tation of a Caz+-activated potassium conductance. 
Compound Synthesis 
Most reagents and solvents used in the syntheses 
were ACS or HPLC grade, and used as received from 
Aldrich, Mallinkradt, Fisher, or J. T. Baker. Dry di- 
methylformamide and dry pyridine were obtained from 
Aldrich, Gold Label, stored over 4A molecular sieves 
and used as received. Potassium salts of 2-nitrophenox- 
ides were prepared by adding a stoichiometric amount 
of concentrated aqueous KOH to the nitrophenol in 
methanol, then evaporating the solvent in vacuo until 
the stoichiometric weight was reached. 
In testing the various reaction products, proton NMR 
spectra were recorded on Varian instruments at 60 
and 100 MHz (HA-100). Peaks are reported below in 
the following format: NMR (solvent, operating fre- 
quency): chemical shift in ppm from tetramethylsilane, 
multiplicity (s=singlet, d=doublet, t =triplet, q=quar- 
tet, m =multiplet, br = broad), spin-spin coupling con- 
stant if appropriate, integrated number of protons. 
Sometimes several adjacent peaks are too close for their 
integrals to be separated, in which case only the total 
integral for a cluster is stated. 
Referring now to the generic formulas shown in the 
Brief Description of the Invention section, supra, and in 
the claims infra, to prepare compounds with X S H ,  
the esters with X=OMe could be demethylated with 
standard reagents such as boron tribromide or trimeth- 
MHz (EM-360), 80 MHz (CFT-20), 90 MHz (EM-390), 
55 
xenon lamp intensity could be increased. (3) The.partic- 60 
ular cell used co%tains a large amount of natural yellow 
pigment that absorbs UV light. Therefore only the 
small fraction of the cell volume most directly facing 
the lens was effectively irradiated. (4) The high ionic 
strength (300-500 mM) present inside a marine inverte- 65 
brate like Aplysia further weakens the binding of Ca2+ 
to unphotolyzed nitr-2. The lower the fraction of nitr-2 
molecules bearing Ca2+ before photolysis, the fewer 
pound may be cleavedand R3, R4, i d  R5may be dealk- 
ylated as well under such conditions, R3, R4, and R5can 
be restored to their original state of alkylation by using 
a suitable diazoalkane or by alkylation with the appro- 
priate alkyl halide in the presence of a weak base such as 
a hindered tertiary amine or potassium carbonate. These 
bases are not strong enough to realkylate the benzylic 
alcohol group, X S H .  
An alternative preparation of the compounds with 
X=OH would be to use the parent aldehydes in place 
of the dimethyl acetals used in the synthesis examples 
described below, as electrophiles toward BAPTA-like 
esters VIa or VIb (see synthesis, infra). Using more 
vigorous conditions such as refluxing in chloroform for 
several days, the reaction of ester VI with 2-nitro-alde- 
hydes in the presence of TMS-triflate and a hindered 
tertiary amine should give the compounds claimed 
12 
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herein, with X=OSi(CH3)3, which will hydrolyze 
spontaneously to X S H  upon aqueous workup. 
Those skilled in the art will realize that starting from 
esters where X a H ,  analogs containing 
X=-O-acetyl,-OCOCF3, -0-glycyl, -0P03H, 5 
-0S02CH3 could be readily prepared by acylation, 
phosphorylation, or methanesulfonylation under stan- 
dard conditions. Also starting from esters where 
X a H ,  analogs with X=-Cl or -Br could be pre- 
pared using SOCl2 or PCl3 or PBr3 or other standard 10 
means for converting alcohols to halides. Esters with 
X=NR6R7 could be prepared from esters with X-Br 
or X=OS02CH3 by nucleophilic substitution under 
standard conditions. 
COMPOUND I1 15 
1-bromo-2-(2'-nitro-5'-methylphenoxy)ethane (11) 
was prepared as follows: 
57.6 g (0.30 mole) potassium 2-nitro-5-methylphenox- 
ide (I), 187.4 g (1.0 mole) 1,2-dibromoethane, and 151 g 20 
dimethylformamide were heated together to 120". The 
bright orange color of the reaction mixture soon faded 
to pale yellow and a white precipitate was deposited. 
After cooling, the precipitate was filtered off and 
washed with water and dichloromethane. The insoluble 25 
residue was 1,2-bis(2-nitro-5-methylphenoxy)ethane, 
5.87 g (0.018 mole). The combined organic phases of the 
filtrate were washed repeatedly with dilute NaOH until 
no more orange color appeared in the extracts, then 
washed once with saturated aqueous NaCl containing a 30 
little NaH2P04. After drying over MgS04, the organic 
phase was evaporated to dryness and the residue recrys- 
tallized either from petroleum ether (b.p. 60"-80") or 
methanol-water. The yield of I1 was 34 g (44%), m.p. 
44"14 45". NMR (CDCl3, 60 MHz): 7.75, d, SHz, 1 H  35 
6.9-6.75, m, 2H, 4.36, t, 7 Hz, 2H; 3.6, t, 7 Hz, 2H; 2.36, 
s, 3H. 
COMPOUND IV 
l-(2-nitrophenoxy)-2-(2'-nitro-5'-methylphenoxy)e- 40 
thane (IV) was prepared as follows: 
5.32 g (20.5 mmole) I1 and 3.98 g (22.5 mmole) potas- 
sium 2-nitrophenoxide (111) were stirred in 10 ml di- 
methylformamide and heated to 130" for 80 min. The 
mixture was cooled, diluted to 100 ml with water, and 45 
filtered; the precipitate was washed repeatedly with 
aqueous Na2CO3 and then water. After drying, it was 
recrystallized from 1.25 1 boiling 95% ethanol contain- 
ing 5 ml acetic acid, to which a little water was added 
after cooling. The yield of IV was 5.55 g, 85%, m.p. 50 
150"-152". NMR (CDC13, 60 MHz): 7.7-6.6, m, 7 H  
4.34, s, 4H, 2.26, s, 3H. 
COMPOUND V 
l-(2-aminophenoxy)-2-(2'-amino-5'-methylphenox- 55 
y)ethane (V) was prepared as follows: 
5.55 g IV were hydrogenated at room temperature 
and atmospheric pressure with 0.46 g palladium (5% on 
charcoal) catalyst in 95% ethanol. After full hydrogen 
uptake (13 hrs), the mixture was warmed, filtered while 60 
hot, decolorized with a pinch of NaBH4, and chilled to 
- 10"; the yield of V as white crystals was 4.03 g, 89%, 
m.p. 118"-119". NMR (CDC13, 80 MHz): 6.8-6.5, m, 
7H; 4.28, s, 4H; 3.5-3.7, br s, 4H; 2.24, s, 3H. 
COMPOUNDS VIa and VIb 
1 -(2-aminophenoxy)-2-(2'-amino-5'-methylphenox- 
y)ethane-N,N,N',N'-tetraacetic acid, tetraethyl ester 
65 
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(VIa) or tetramethyl ester (VIb) were prepared by ei- 
ther of two methods, as follows: 
2.58 g (10 mM) V, 11.3 g (53 mM) l,S-bis(dime- 
thylamino)naphthalene, 0.79 g (5.3 mM) sodium iodide, 
8.91 g (53 mM) ethyl bromoacetate, and 9.5 g acetoni- 
trile were stirred and refluxed under nitrogen for 18 hrs. 
The cooled mixture was diluted with toluene and fil- 
tered. The filtrate was extracted with phosphate buffer 
at pH 2 until the 1,8-bis(dimethylamino)naphthalene 
was removed. The toluene solution was dried and evap- 
orated and the residue recrystallized from 50 ml etha- 
nol. The yield of the tetraethyl ester, VIa, was 5.27 g, 
87%, m.p. 110"-110.5". NMR (CDCl3, 100 MHz): 
6.88-6.6, m, 7H, 4.30, s, 4H, overlapping 4.18, s, 4.14, s, 
4.08, q, 7 Hz, total 16H; 2.28, s, 3H; 1.18, t, 7 Hz, 12H. 
In a larger-scale repetition, ethyl bromoacetate was 
replaced by methyl bromoacetate and I,S-bis(dime- 
thy1amino)naphthalene was replaced by Na2HP04, 
dried at 150". Thus 25.83 g (100 mM) V, 71 g (500 mM) 
dried Na2HP04, 5.9 g (39 mM) NaI, 84.7 g (554 mM) 
BrCH2C02Me and 104 g CH3CN refluxed under nitro- 
gen with vigorous stirring by a crescent-shaped paddle 
for 18 hrs. The cooled reaction mixture was partitioned 
between water and toluene. The organic phase was 
evaporated to dryness and recrystallized from metha- 
nol. The yield of the tetramethyl ester, VIb, was 40.2 g 
(7 1 %). After another crystallization from methanol, the 
m.p. was 95"-95.50". NMR (CDCl3, 90 MHz): 6.83, s, 
6.67, m, total 7H; 4.24, s, 4.13, s, 4.09, s, total 12H, 3.56, 
s, 3.54, s, total 12H; 2.23, s, 3H. 
COMPOUND VI1 
1 -(2-amino-5-( 1 -methoxy- 1 -(2-nitrophenyl) methyl)- 
phenoxy)-2-(2'-amino-5'-methy1phenoxy)- ethane- 
N,N,N',N'-tetraacetic acid, tetramethyl ester (VII) was 
prepared as follows: 
0.2 mmole VIb, 200 mg 2-nitrobenzaIdehyde di- 
methyl acetal (prepared from 2-nitrobenzaldehyde by 
standard means, i.e., transacetalization with trimethyl 
orthoformate), 4 ml CH~Cl2,0.2 ml trimethylsilyl triflu- 
oromethanesulfonate, and 0.2 ml 2,6-di tertbutylpyri- 
dine were combined and left at room temperature for 24 
hrs. The organic phase was equilibrated with aqueous 
NaHCO3, dried over MgS04, evaporated to dryness, 
and chromatographed on silica with toluene-ethyl ace- 
tate 4:1 v/v as eluant. The product with higher RFand 
a tendency to turn yellow upon UV illumination was 
collected. NMR (cc13, 90 MHz): 7.9-7.1, m, 4-5H; 
6.9-6.5,m, 6-7H; 5.83, s, lH;4.3-4.0,m, 12-14H; 3.55, 
s, 3.50, s, total 12-14H; 3.28, s, 3H; 2.20, s, 3H. 
COMPOUND VI11 
1 -(2-amino-5-( 1 -methoxy- 1-(2-nitrophenyl) methyl)- 
phenoxy)-2-(2'-amino-5'-methylphenoxy)- ethane- 
N,N,N,N-tetraacetic acid (VIII) was prepared as fol- 
lows: 
VI1 was saponified by dissolving 43 mg (70 micro- 
moles) VI1 in a mixture of 0.5 ml dioxane, 1.0 ml metha- 
nol, and 0.4 ml 1N NaOH. This mixture was left in 
darkness overnight. 
COMPOUND IX 
2-nitro-4,5-methylenedioxybenzaldehyde, dimethyl 
acetal (IX) was obtained by reaction of 6-nitropiperonal 
with excess methoxytrimethysilane in the presence of 
trimethylsilyl trifluoromethanesulfonate in CHrCl2 at 
-78" C., according to the general procedure of Noyori, 
(1 982). 
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COMPOUND X 
1-(2-amino-5-( 1-methoxy- 1 -(2-nitro-4,5-methylenedi- 
oxyphenyl)methyl)phenoxy)-2-(2'-amino-5'-methyl- 
phenoxy)ethane-N,N,N',N'-tetraacetic acid, tetraethyl 
ester (X) was prepared as follows: 
602 mg (1 mmol) VIa and 0.4 ml 2,6-di-t-butylpyri- 
dine (0.4 ml) were dissolved in 10 ml of dry dichloro- 
methane, with stirring, under nitrogen and cooled to 0". 
To this mixture was added 0.3 ml trimethylsilyltri- 
fluoromethanesulfonate in one portion. After 10 min- 
utes, 0.4 g of 2-nitro-4,5-methylenedioxybenzaldehyde, 
dimethyl acetyl, IX (dissolved in 5 ml dry CH2C12) was 
added dropwise from a syringe over 40 min. From this 
point onward, the materials were protected from short- 
wavelength light as much as possible by wrapping the 
reaction vessels in aluminum foil and working under a 
yellow safelight. The reaction was stirred at 0" for three 
hours more, then diluted with dichloromethane and 
washed with aqueous NaHC03. The organic layer was 
dried with anhydrous sodium sulfate in darkness, fil- 
tered, and evaporated. The syrupy residue was chro- 
matographed on silica gel, eluting with toluene-ethyl 
acetate 4:l (v/v). The yield was 0.598 g, 74%, of a thick 
syrup, pure by TLC and by NMR (trace of toluene). 
NMR (CDCI3, 90 MHz): 7.3-7.1, m; 6.9-6.6, m; 6.0, s; 
5.88, s; 4.3-3.9, m; 3.29, s; 2.20, s; 1.12, t, 7 Hz. 
COMPOUND XI 
1 -(2-amino-5-( 1 -methoxy- 1 -(2-nitro-4,5-methylenedi- 
oxyphenyl)methyl)phenoxy)-2-(2'-amino-5'-methyl- 
phenoxy)ethane-N,N,N',N'-tetraacetic acid (XI). 
Ester X was saponified by dissolving 78 mg (0.096 
mmole) X in 2 ml dioxane, 1 ml methanol, and 0.8 ml1N 
NaOH, and leaving this mixture overnight at room 
temperature, protected from light. 
COMPOUND XI1 
2,6-dinitro-3-methoxybenzaldehyde, dimethyl acetal 
(XII) was prepared by the same method used for mak- 
ing compound IX but using 2,6-dinitro-3-methoxyben- 
zaldehyde, for a starting material and reacting over- 
night at room temperature instead of -78". After wash- 
ing with aqueous NaHCO3, drying, and evaporating the 
solvent, the product was pure by TLC and NMR. 
COMPOUND XI11 
1 -(2-amino-5-( 1 -methoxy- 1 -(2,6-dinitro-3-methoxy- 
phenyl)methyl)phenoxy)-2-(2'-amino-5'-methylphenox- 
y)ethane-N,N,N',N'-tetraacetic acid, tetramethyl ester 
(XIII) was prepared as by the same method used to 
make compound X, except starting with VIb instead of 
VIa and XI1 in place of IX and stirring overnight at 
room temperature instead of three hours at 0". The 
product was purified by preparative thin layer chroma- 
tography on silica gel plates, eluting with hexane-ethyl 
acetate 1:l. NMR (CDC13, 90 MHz): 7.85, d, 9 Hz, 1H; 
6.95, d, 9 Hz, 1H; 6.85-6.45, m, 6H; 5.86, s, 1H; 4.12, s, 
4 H  4.02, s, 3.98, s, total 8H; 3.85, s, 3H; 3.43, s, 3.41, s, 
total 12H; 3.22, s, 3H, 2.14, s, 3H. 
COMPOUND XIV 
1 -(2-amino-5-( 1 -methoxy- 1 -(2,6-dinitro-3-methoxy- 
pheny1)methyl) phenoxy)-2-(2'-amino-5'-methyl- 
phenoxy)ethane-N,N,N,N'-tetraacetic acid (XIV) was 
prepared as follows: 
20 micromoles of XI11 was saponified in a mixture of 
0.6 ml dioxane, 0.2 ml methanol, and 0.2 ml 1M KOH, 
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standing overnight at room temperature, protected 
from light. 
COMPOUND XVI 
1,4-di(benzyloxy)benzene (XVI) was prepared as 
follows: 
To a stirred suspension of 55 g (0.5 mole) hydroqui- 
none (XV) and 143.1 g (1.1 mole) benzyl chloride in 100 
ml ethanol was added a solution of 60.2 g (0.91 mole) 
potassium hydroxide in ethanol. After 1 hr, the mixture 
was poured into water. The precipitate was filtered off 
several hours later, dried at 70", and recrystallized from 
3.5 liters of boiling ethanol. The yield of XIX was 105 g, 
73%, m.p. 128"-130" (literature values (32) range from 
126.5 to 130"). NMR (CDC13, 100 MHz): 7.35, S, IOH, 
6.87, s, 4 H  4.98, s, 4H. 
COMPOUND XVII 
2-nitro-l,4-di(benzyloxy)benzene (XVII) was pre- 
pared as follows: 
18 3 g (0.203 mole) 70% aqueous nitric acid were 
diluted to 50 ml with glacial acetic acid and added to a 
suspension of 58 g (0.200 mole) XVI in 200 ml acetic 
acid. The mixture was stirred and gently warmed to 50", 
whereupon the starting material dissolved and product 
began to crystallize out. After cooling the mixture and 
filtering off a first crop, water was added dropwise to 
precipitate a second crop. The total yield of XVII was 
65.6 g, 98%, m.p. 81"-82.5" (83" was reported in ref. 33). 
NMR (CDCl3, 100 MHz): 7.5-6.9, M, 13H; 5.15, s, 5.03, 
s, total 4H. 
COMPOUND XVIII 
2-nitro-4-benzyloxyphenol (XVIII) was prepared as 
follows: 
A solution of 50.4 g (0.15 mole) XVII in 100 ml 
ethanol-free chloroform was treated with 15.0 ml (0.2 
mole) trifluoroacetic acid and kept at room temperature 
for 48 hours, at which time an NMR spectrum showed 
ca. 90% conversion of the starting material, as judged 
by the amplitude of the peak at =4.92. The excess acid 
was neutralized with 5M aqueous potassium hydroxide. 
The organic phase was repeatedly extracted with dilute 
aqueous potassium carbonate until the aqueous layer 
was pale orange instead of dark brown as at first. The 
chloroform solution was then diluted with 1.5 volumes 
of diethyl ether and treated with 60 ml 5M potassium 
hydroxide. The dark red precipitate of potassium 4-ben- 
zyloxy-2-nitrophenoxide was filtered off, acidified with 
dilute HCI, and extracted with six 600 mi portions of 
petroleum ether (b.p. 60"-80"). After combining the 
extracts and evaporating the petroleum ether, the resi- 
due was recrystallized from boiling methanol to which 
water was added dropwise after cooling. The yield of 
XVIII was 31-32 g, 84-87%, m.p. 67"-70". 
NMR (CCl4, 100 MHz): 10.24, s, 1H; 7.52, d, 3 Hz, 
1 H  7.32, s, 5H; 7.19, dd, 3 Hz, and 9 Hz, 1H; 7.00, d, 
COMPOUND XIX 
1 -(2-nitro-4-benzyloxyphenoxy)-2-(2'-nitro-5'- 
methy1phenoxy)ethane (XIX) was prepared as follows: 
A mixture of 2.45 g (10 mmole) XVIII, 2.8 g (108 
mmole) 11,0.76 g (5.5 mM) anhydrous K2CO3, and 5 ml 
dimethylformamide was heated to 150" and stirred for 
15 min. While still fairly warm, the stirred mixture was 
treated dropwise with water until the initial deposit of 
KBr dissolved and the product began to crystallize. It 
J=9 Hz, 1H; 5.01, S, 2H. 
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was filtered off, dried (crude yield 90%), and recrystal- 
lized by dissolving in a minimum quantity of hot ace- 
tone and precipitating with twice its volume of petro- 
leum ether. The light yellow crystals of XIX had m.p. 
COMPOUND XX 
1 -(2-amino-4-benzyloxyphenoxy)-2-(2'-amino-5'- 
methy1phenoxy)ethane (XX) was prepared as follows: 
5 g (11.8 mmole) XIX and 0.5 g of 5% platinum on 
charcoal were suspended in 100 ml absolute ethanol and 
stirred under hydrogen. The theoretical volume was 
taken up in 5 hrs. but the mixture was left under hydro- 
gen overnight, after which the cumulative uptake was 
19% higher than theoretical. Another 5 g of XIX added 
to the same hydrogenation mixture also took up the 
same higher-than-theoretical amount of hydrogen over- 
night. The product XX was recrystallized from acetone 
and had melting point 129"-132". The NMR spectrum 
143"-144". 
18 
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was carefully distilled to remove CH3COOCH20CH- 
2OCOCH3. 
EXAMPLES 
Specific properties and embodiments of the present 
invention are outlined in the following examples. Such 
examples are for illustrative purposes only and are not 
intended to limit the scope of the claims in any way. 
EXAMPLE I 
Chemical tests 
Nitr-1 and nitr-2 were tested in vitro by diluting the 
saponification solutions to final chelator concentrations 
of between 4 and 50 micromole in aqueous buffers con- 
I5 taining 100 mmole KCI and known Ca2+ concentra- 
tions ranging from < 1O-lOM to > lO-3M. The choice 
of chelator concentration was merely to give conve- 
nient optical densities in 1 cm cuvets. Although these 
5 
10 
- 
showed that the- benzyl groups had not been lost. 2o compounds will photolyze upon illumination with ultra- 
m, 4H; 6.32, d, 3 H ~ ,  1 ~ ;  6.12, dd, 3 H~ +7 H ~ ,  1 ~ ;  to use low enough light levels so that measuring absor- 
4.93, s, 2H, 4.3, br s, 4.26, s, total 4H; 2.27, s, 3H. bance spectra caused negligible photochemical reac- 
tion. UV absorbance spectra of separate samples of 
(CDC13+CD3SOCD3, 90 MHz): 7.29, s, 5H; 6.75-6.45, violet light, the uv spectrophotometer used was found 
The toluene solution was then washed with water and 
dried over MgS04. After evaporation of the toluene 
under reduced pressure, the residue was washed with 
petroleum ether-ethyl acetate 9:l v/v to remove traces 
of ethyl bromoacetate. The yield of XXI was 6.4 g 45 
(90%), m.p. 95"-96". 
COMPOUND XXII 
1 -(2-amino-4-hydroxy-phenoxy)-2-(2'-amino-5'- 
methy1phenoxy)ethane-N,N,N',N'-tetraacetic .acid, tet- 50 
raethyl ester (XXII) was prepared as follows: 
XXI was debenzylated by hydrogenation in glacial 
acetic acid with 5% Pd on charcoal catalyst at atmo- 
spheric pressure. 
Acetoxymethyl bromide 
Acetoxymethyl bromide, CH3COOCH2Br, was pre- 
pared by stirring 4.0 g (30 mM) methylene diacetate and 
5.0 g (33 mM) trimethylsilyl bromide, in the presence of 
60 mg anhydrous ZnClz but no added solvent, for 48 hr 60 
at &om temperature. The product was distilled crudely 
at 10 torr, 40"-60" then refractionated through a Vi- 
greaux column at 10 torr, 55"-57", yielding 4.04 g, 87%, 
containing no detectable BrCH20CH2Br by NMR. 
Lewis acid catalysis is essential; without it there is no 65 
reaction even at 1 lo" in a sealed tube overnight. Methy- 
lene diacetate was prepared from paraformaldehyde 
and acetic anhydride (see Knoevenagel, E., 1913) and 
55 
COMPOUND XXI 25 nitr-1, nitr-2, and nitr-3, titrated with buffered Ca2+ 
solutions, were measured, avoiding significant exposure 
me thy~phenoxy)e thane -~ ,~ ,~ ,~ - t e t r ace t~c  id, tet- to ultraviolet light. A family of such curves is shown in 
raethyl ester (XXIV) was prepared as follows: FIG. 3 for the titration of nitr-2 with Ca2+. Using these 
3.64 (10 mmole) XX, 10.72 (50 mmole) 1,8-bis(- curves and others (not shown), the Ca2+ dissociation 
dimethy]amino)naphtha]ene, 2.0 (13 mmole) dried 3o constants of each of nitr-1, nitr-2, and nitr-3 were deter- 
NaI, 8.35 g (50 mmole) ethyl bromoacetate, and 15 ml mined to be about 160 n'.
acetonitrile were stirred and refluxed under nitrogen for Other samples of nitr-I, nitr-2, and nitr-3, plus either 
, 
40 hrs, with a further addition of 1.5 ml ethyl bromoace- mM EDTA Or EGTA Or mM Ca2+, were irradiated 
tate and 2 g 1,8-bis(dimethylamino)naphthalene after at 254 Or 365 nm using a hand mercury lamp fixed at a 
the first 24 hrs. The cooled reaction mixture was evapo- 35 known distance from the sample, which Was stirred in a 
rated to dryness, diluted with toluene and filtered; the 1 cm uv cuvette. uv spectra were measured Periodi- 
gray precipitate was washed repeatedly with further Cally to follow the photolysis reaction. IlIUminatiOn 
small portions of toluene. The pooled toluene solutions intensities were measured by ferrioxalate actinometry 
1-(2-amino-4-benzyloxyphenoxy)-2-(2'-amino-5'- 
were repeatedly extracted with phosphate buffer until (see Hatchard, et a1.9 1956) and approximately con- 
the washings had the same DH (2) as the fresh buffer. 40 firmed by a bolometer (yellow Springs Instrument CO. 
YSI-65A). FIG. 4 illustrates remesentative curves 
showing changes seen in the absorbtion spectrum of 4 
microM nitr-2, illuminated at 365 nm in EGTA and no 
Ca*+. With each dye, photolysis caused a large increase 
in extinction near 370-380 nm, which is attributed to 
conjugation of the amino nitrogen with the ketone moi- 
ety. For example, the extinction coefficient of nitr-2 
irradiated in zero [Ca2+] increases from 3500 to 17,500 
M-lcm-1 at 380 nm (see FIG. 4). With illumination 
intensity of 7.8X 10-9 einsteins cm-2-sec-1 (1 ein- 
stein = 6.02 X 1023 photons) at 365 nm, the time course of 
the change in extinction coefficient was a decaying 
exponential whose time to reach 90% completion was 
about 20 min (see FIG. 2), indicating a quantum effi- 
ciency of about 0.03. If a sample of nitr-2 is photolysed 
in high [Ca2+], the change in absorbance (FIG. 5) is less 
marked at 370-380 nm but is most pronounced at 320 
nm, at which the extinction coefficient changes from 
2800 to 11,600 M-1cm-1. This change requires some- 
what less total exposure to 365 nm irradiation, 6 min for 
90% completion, corresponding to a quantum effi- 
ciency of 0.1. The measured quantum efficiencies of 
nitr-3 for photolysis with 365 nm light were 0.015 with 
no calcium and 0.042 with 1 mM Ca2+ (data not 
shown). 
After photolysis, dissociation constants of each com- 
pound were determined by titrating photolyzed samples 
of nitr-1, nitr-2, and nitr-3 with Ca2+. FIG. 6 shows a 
4,689,432 
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representative family of spectra for Ca2+ titration of 
Summary nitr-2 after photolysis (compare with FIG. 3). Each 
photolyzed compound was found to have a dissociation Thus it can be seen that the present invention dis- 
constant for Ca2+ in the range of 6-10 microM, repre- closes novel photolabile Ca2+ chelators that store 
senting substantially weaker (40-60 fold) binding than 5 Ca2+ in a physiologically inactive form until illumi- 
before photolysis. With nitr 2 it was possible to confirm nated with ultraviolet light, whereupon the Ca2+ tends 
that 365 nm photolysis yielded the same covalent rear- to be released. This released Ca2+ is then free to acti- 
rangement whether carried out in high or low [Ca2+], vate physiological processes. Since the new chelators 
Le., raising [Ca2+] then photolysing resulted in the same disclosed herein make it possible to now use light to 
spectrum as photolysing in low [Ca2+], then raising 10 control the release of Ca*+ inside cells they will be 
[Ca2:]. Nitr-1 was not so well behaved, due possibly to extremely useful to biological researchers trying to 
impurities or to the more generally destructive effects study the many cellular functions that calcium is now 
of the 254 nm radiation used. believed to control. 
The stable states of nitr-2 can be summarized by the It can also be seen that the present invention discloses 
diagram shown in Table I. 15 an improved method for synthesizing 1-hydroxy- or 
TABLE I 
NITR-2 (a nitrobenzhydrol) *> a nitrobenzophenone 
lambda max = 356 nm (4100) irreversible 380 nm (17,500) 
253 nm (21,500) FIG. 4 250 nm (20,200) 
reversible 
Kd- 7 microM 
reversible 
Kd- 160 nM j 1 
Ca2+ NITR-2 s+ Ca2+.nitrobenzophenone 
356 nm (3800) irreversible 390 nm (7000) 
279 nm (7000) FIG 5 324 nm (11,600) 
237 nm (18,600) 283 nm (12,600) 
232 nm (20,403) 
lambda max in nm (extinction coefficient) 
Q = quantum eficiency 
The FIGS referred to in the diagram above relate to the associated processes shown graphically in FIGS 3-6 
4o 1 -alkoxy-l-(2-nitroaryl)- 1 -aryl methanes. Methanes of 
this type are either critical to the preparation of, or 
actually constitute, the photolabile Ca2+ chelating com- 
pounds disclosed and discussed herein. 
Various modifications of the invention in addition to 
to those skilled in the art from the foregoing description 
and accompanying drawings. Such modifications are 
EXAMPLE I1 
Biological Tests 
To demonstrate one use of photolabile Ca2+ chela- 
was used to show changes in membrane conductance. It 
is well known that increasing intracellular free [Ca2+] 
for a review). This current can be detected either by 
potential, or by direct measurement of the current when 
the membrane potential is held constant by a voltage 
clamp technique. Both of these methods were used by 
Dr. R. S. Zucker, who tested nitr-2 in a single neuron 
preparation (L2 in the abdominal ganglion) in the sea 55 
hare Aplysia californica. A solution was injected into the 
cell to give approximately 8 mM nitr-2 and 6 mM Ca2+. 
The transmembrane potential was then measured. 
When the cell was illuminated with light from a 75 watt 
xenon lamp, there was hyperpolarization of about 0.9 60 
mV (see FIG. 7). This change is not due to the effects of 
the light on the preparation, since uninjected control 
cells showed no response to the illumination. 
In another experiment, measuring current under volt- 
age clamp conditions (-45 mV) showed a small out- 65 
ward current due to illumination of a similarly injected 
cell (see FIG. 8). Again, the uninjected control cell 
showed no such change. 
tors disclosed herein a representative compound (nitr-2) 45 those shown and described become apparent 
causes changes in potassium current (see Meech, ('978) intended to within the scope Of the appended 
What is is: 
showing an increase of negativity in the membrane 50 1. A chemical having the general 
R3 
and the pharmaceutically acceptable non-toxic salts and 
esters thereof wherein: 
A is -NO2 or -H; 
21 
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Rl is selected from the group comprised of -H (un- 
less R2 is also H), -CH3, -F, -C1, and -Br; 
R2 is selected from the group comprised of -H (un- 
less RI is also H), -CH3, -F, -C1, -Br, ci-C4 
alkoxy; 
R3, R4and R5are independently -H, OH, NR6R7, or 
alkoxy, or 
R3 and R4 together are -0CH20- or -0CH2C- 
H20- and R5 is -H, OH, NR6R7, or alkoxy, or 
R4 and R5 together are -0CH20- or OCH2C- 
H20- and R3 is -H, OH, NR6R7, or alkoxy; 
X is selected from the group comprised of -OH, 
alkoxy, -C1, -Br, -NR6R7, -0COCH3, -0- 
COCF3, -0COCH2NH2, -OPO3H, and -0- 15 
S02CH3; 
R6 and R7 are independently -H, methyl or ethyl; 
D is 0, N, NH, or N alkyl; 
Q is a double bond when D is N and a single bond 
Rg is H and R9 is H or 
Rg and R9, together with heteroatom D, the carbon 
adjacent RS, and the phenyl ring adjacent to R9, 
form a quinoline ring system (D=N, Q==double 
bond); and 25 
otherwise; 20 
W is -H, -OH, or -NHR6, or alkoxy. 
2. A chemical compound having the general formula: 
L.(H'o* 
35 
and the pharmaceutically acceptable non-toxic salts and 
esters thereof wherein: 45 
A is -NO2 or -H 
22 
R3, R4and R5 are independently -H, OH, NR6R7, or 
alkoxy, or 
R3 and R4 together are -0CH20- or -0CH2C- 
H20- and R5 is -H, OH, NR6R7, or alkoxy, or 
R4 and R5 together are -0CH20- or -0CH2C- 
H20- and R3 is -H, OH, NR6R7, or alkoxy; 
X is selected from the group comprised of -OH, 
alkoxy, -C1, -Br, -NR6R7, -0COCH3, -0- 
COCF3, -0COCH2NH2, -0P03H, and -0- 
S02CH3; 
R6 and R7 are independently -H, methyl or ethyl; 
D is 0, N, NH, or N alkyl; 
Q is a double bond when D is N and a single bond 
Rg is H and R9 is H or 
Rg and R9, togehter with heteroatom D, the carbon 
adjacent to Rg, and the phenyl ring adjacent to R9, 
form quinoline ring system (D=N, Q=double 
bond); and 
otherwise; 
W is -H, -OH, or NHR6, or alkoxy. 
3. The compound of claim 1 wherein said tetraacetic 
acid esters are alpha-acyloxyalkyl esters. 
4. The compound of claim 3 wherein said alpha- 
acyloxyalkyl esters are acetoxymethyl esters. 
5. The compound of claim 1 wherein R2 is methyl. 
6. The compound of claim 1 wherein D=O and 
7. The compound of claim 2 wherein said tetraacetic 
8. The compound of claim 7 wherein said alpha- 
9. The compound of claim 2 wherein R2 is methyl. 
10. The compound of claim 2 wherein D=O and 
11. The compound 1-(2-amino-5-(l-methoxy-l-(2- 
Rg=Rg=H. 
acid esters are alpha-acyloxyalkyl esters. 
acyloxyalkyl esters are acetoxymethyl esters. 
Rg=R9=H. 
nitrophenyl)methyl)-phenoxy)-2-(2'-amino-5'-methyl- 
phenoxy)ethane-N,N,N',N tetraacetic acid. 
12. The compound l-(2-amino-5-( 1-methoxy-l-(2- 
nitro-4,5-methylenedioxyphenyl)me thy1)-phenoxy)-2- 
(2'-amino-5'-methylphenoxy)-ethane-N,N,N',N'-tetraa- 
cetic acid. 
13. The compound 1-(2-amino-5-(l-methoxy-1-(2,6- 
dinitro-3-methoxyphenyl))methylphenoxy)-2-(2'- 
amino-5'-methylphenoxy)-ethane,N,N,N',N tetraacetic 
acid. * * * * *  
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